Summary:
This research study is investigating troriluzole (BHV-4157) as a possible treatment for Obsessive Compulsive Disorder (OCD).
To be eligible to participate you must be on a stable dose of a single standard of care medication for OCD and experiencing an inadequate response.
Qualified Participants May Receive:
Qualified participants may receive compensation for completed visits, study-related medical care and investigational medication at no cost. Additional assistance with transportation may be available.